Humana HUM
$390.00 +$10.00 (+2.63%)
Market closed · Nov 20, 9:40 pm ET · Last extended-hours $382.07 -2.03%
Open$392.54
Prev close$380.00
Day range$387.83 – $401.98
Volume2.32M
Market cap$46.84B
P/E (TTM)38.0
Dividend yield0.68%
Earnings
Average move on report day±5.2%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+12.4%
Worst reaction-11.7%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 6 Nov 2026 | Pre Market | ±8.1% | +5.33% | Within range |
| 2026/Q2 | 29 Jul 2026 | Pre Market | ±8.4% | -5.99% | Within range |
| 2026/Q1 | 29 Apr 2026 | Pre Market | ±8.0% | +5.83% | Within range |
| 2025/Q4 | 11 Feb 2026 | Pre Market | ±9.7% | -3.25% | Within range |
| 2025/Q3 | 5 Nov 2025 | Pre Market | ±7.0% | -6.01% | Within range |
| 2025/Q2 | 30 Jul 2025 | Pre Market | ±7.7% | +12.40% | Bigger than priced |
| 2025/Q1 | 30 Apr 2025 | Pre Market | ±9.3% | +1.11% | Within range |
| 2024/Q4 | 11 Feb 2025 | Pre Market | ±7.3% | -3.55% | Within range |
| 2024/Q3 | 30 Oct 2024 | Pre Market | ±7.1% | +3.32% | Within range |
| 2024/Q2 | 31 Jul 2024 | Pre Market | ±6.4% | -10.61% | Bigger than priced |
| 2023/Q4 | 25 Jan 2024 | Pre Market | ±4.9% | -11.69% | Bigger than priced |
| 2023/Q3 | 1 Nov 2023 | Pre Market | ±3.8% | -6.56% | Bigger than priced |
| 2023/Q2 | 2 Aug 2023 | Pre Market | ±4.5% | +5.60% | Bigger than priced |
| 2023/Q1 | 26 Apr 2023 | Pre Market | ±3.1% | +0.75% | Within range |
| 2022/Q4 | 1 Feb 2023 | Pre Market | ±3.8% | +0.31% | Within range |
| 2022/Q3 | 2 Nov 2022 | Pre Market | ±3.9% | +0.92% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$41.16B+26.1% YoY
Net profit$161.00M-17.0% YoY
Diluted EPS$1.35-16.7% YoY
Free cash flow$2.03B+142.3% YoY
Operating cash flow$2.16B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Net margin0.8%
Return on equity6.7%
Return on assets2.3%
Liabilities / assets67.0%
Total debt$12.50B
Free cash flow / sales2.0%
No comments yet — be the first to weigh in on HUM.
Sign in to join the discussion.